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ABSTRACT: 
Background: The number of patients with End Stage Renal Disease (ESRD)  is growing 
annually around the world. Provision of renal replacement therapy in the form of dialysis and 
transplant is relatively expensive. Recent studies have shown no survival benefit of early 
initiation of dialysis. Given recent outcome data of the timing of dialysis treatment and the 
expenses  and logistics  of hemodialysis procedure have stimulated research on  alternative 
strategies. The aim of this study is to introduce another type of renal replacement therapy for 
selective patients with advanced chronic kidney disease (CKD). 
 
Methods: In a case series we used a so-called “dialysis free protocol” consisting of a low 
protein diet, uremic toxin adsorbents, and prebiotics for selective ESRD patients who had 
dialysis access constraints or did not agree placement of hemodialysis vascular access or 
peritoneal dialysis catheter.  
 
Findings: clinical and biochemical results of this study showed that  these patients were not 
deteriorating  during  the  study  period  and  Blood  Urea  Nitrogen  (Bun)  &  serum  creatinin 
levels  were  not  elevated  in  these  months.  Participating  patients  were  relatively  well 
throughout the study without signs of florid uremia and without a need for emergent or urgent 
dialysis.  
 
Conclusion:  We  conclude  that  our  proposed  dialysis  free  protocol  reduces  the  need  for 
dialysis treatment at least transiently. Whether this protocol can reduce the need for dialysis 
treatment requires additional studies.  
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INTRODUCTION:  The  number  of  patients  who  require  renal  replacement  therapy  is 
increasing all around the globe. The rising need for dialysis and renal transplant can only be Functional Foods in Health and Disease 2012, 2(8):300-306                                                      Page 301 of 306  
dealt with at enormous expense. It is clear that resources to support this expansive growth are 
limited,  both  in  developing  and  developed  countries  (1).  The  few  alternatively  available 
treatments for pre-dialysis patients and the expensive hemodialysis procedure has stimulated 
research on alternative strategies which might help delay the need for dialysis and improve 
overall health (2,3). The potential benefit of low protein diets for uremic patients has long 
been debated. Diet modification in uremia should relieve uremic symptoms, correct some of 
the complications seen in kidney failure, and preserve or improve the nutritional state of 
patients (4-6). Prebiotics on the other hand, as a non-digestible food beneficially affects the 
host by selectively stimulating the growth and /or activity of one or a limited number of 
bacteria (usually bifidobacteria and lactobacilli) in the colon and thus improves host health 
(7-9). Previous experience suggests that oral  administration of a probiotic formulation of 
selected microbial strains may extend renoprotection via intraintestinal extraction of toxic 
waste solutes in patients with chronic kidney disease (CKD) stages 3 and 4 (10). 
There
 have been several reports in addition that suggest the administration of activated 
charcoal and AST-120
 retards the progression of CRF in both uremic rats and
 undialysed 
uremic patients. At present, AST-120 is widely used as
 an approved drug in Japan for the 
treatment of approximately
 20,000 undialysed uremic patients to delay the progression
 of 
CRF. However, AST-120 is not yet available outside Japan (11-12). The aim of our proposed 
dialysis free protocol is to introduce another type of renal replacement therapy for selective 
patients with advanced CKD.  
 
METHODS: In a case  series  we used a  so-called “dialysis free protocol” including low 
protein diet, uremic toxin adsorbents and prebiotics for selective ESRD patients who have 
dialysis access constraints or did not agree to the placement of a hemodialysis vascular access 
port or a peritoneal dialysis catheter. Our protocol includes a three directional way to reduce 
or eliminate the nitrogenous waste product in ESRD patients, and delay or alleviate the need 
for dialysis for at least a short period in these patients [1- low protein diet, 0.6-0.8 g/kg with 
high biologic value, supplemented with carbohydrates and polyunsaturated fat. 2- Activated 
charcoal,  at  a  dose  of  15  grams  (powder),  was  diluted  in  a  small  glass  of  water  as  an 
absorbent of nitrogenous waste product (intestinal dialysis). It was administered after each 
meal, far from other medications. 3- Lactulose as an accessible prebiotic,30 ml (20g)3 time 
per day in order to change the gastrointestinal microflora to health bacteria and reduction of 
nitrogenous waste product by good bacteria for absorption to the blood]. BUN, Creatinin, 
Na+, K+, lipids CBC, were measured periodically during the study. Patient's clinical status 
was controlled for any deterioration or need to dialyze. All data were collected at the end of 
study for analysis.  
 
CASES:    
Case 1: A 25 year old man with ESRD secondary to Alport syndrome started hemodialysis 
two sessions (8 hours) per week 3 months ago. His sister received a renal transplant 3 years 
ago. He received a renal transplant after 6 months dialysis from a living unrelated donor, but 
the allograft was removed due to technical problems and allograft vein thrombosis without 
function after 5 days. Due to dialysis incompliance and access failure, he fit our dialysis free 
protocol. Renal function was tested (blood urea, serum creatinin), electrolytes were evaluated 
every two weeks and CBC, serum lipids and albumin were tested monthly. After the six 
month  dialysis  free  period,  he  was  well  and  active  and  in  clinically  and  para-clinically Functional Foods in Health and Disease 2012, 2(8):300-306                                                      Page 302 of 306  
reasonable condition. Physical examination revealed an active thin man with Bp= 140/85 
mmhg without uremic symptoms and signs. He was on other medications for treatment of 
anemia (erythropoietin, folate, vitamins), renal osteodystrophy (active vitamin D, calcium 
carbonate,) and hypertension. His body mass index (BMI) was 18.3 that not differ during the 
study. Now he is a candidate for re-transplantation (Table 1). 
 
Table 1.  Renal replacement therapy for selective patients with advanced chronic kidney 
disease 
 
  Case 1  Case 2  Case 3  Case 4  Case 5 
Blood Urea mg/dl           
   Baseline  149  140  322  220  186 
   Month 2  155  169  414  205  208 
   Month 4  140  145  350  305  192 
   Month 6  150  150  202  201  168 
   Month 8    115       
   Month 10    130       
Serum Creatinine 
mg/dl 
         
   Baseline  6.8  6.1  22  8.1  7.6 
   Month 2  6.5  5.8  17.2  8.5  5.3 
   Month 4  6.0  6.6  13.9  7.4  6.0 
   Month 6  5.6  6.7  12.9  8.5  4.8 
   Month 8    6       
   Month 10    6       
Hemoglobin g/dl           
   Baseline  8.9  9.8  8.8  11.0  8.2 
   Month 2  10.8  10.9  9.2  11.8  9.4 
   Month 4  11.0  11.2  9.9  13.0  9.7 
   Month 6  11.6  12.0  10.3  11.8  10.8 
   Month 8    10.6       
   Month 10    10.7       
Cholesterol mg/dl           
   Baseline  169  150  170  140  112 
   Month 2  158  138  174  127  121 
   Month 4  170  153  165  129  108 
   Month 6  153  130  167  146  127 
   Month 8    137       
   Month 10    158       
 
Case 2: A 60 year old woman with ESRD due to hypertension started chronic hemodialysis 
15 months ago. She was on dialysis for 5 months with access problems. After that, due to 
access failures and disagreement with continuing of dialysis, she fit our dialysis free protocol. 
She was clinically under control, and renal function tests, electrolytes, CBC, and nutritional 
status (lipids and albumin) were measured biweekly and monthly according to clinical status. 
She was well without uremic symptoms after 10 months on this regimen. She was also on Functional Foods in Health and Disease 2012, 2(8):300-306                                                      Page 303 of 306  
other medications for treatment of anemia, renal osteodystrophy edema as in Case 1. Her 
BMI was stable during dialysis freedom period and persistently more than 25 (Table 1). 
 
Case 3: A 29 year old man with ESRD due to Alport syndrome started hemodialysis due to 
uremia and need for renal replacement therapy. He was on hemodialysis for 3 months. Due to 
Atrio-enous  fistula  failure,  hemodialysis  was  stopped.  He  did  not  agree  with  short  term 
central venous catheter insertion. Due to access failure and with patient’s agreement, dialysis 
freedom  protocol  was  started.  He  was  clinically  under  control  and  renal  function  tests, 
electrolytes,  CBC  and  nutritional  status  were  evaluated  biweekly  and  monthly  as  above 
patients. Other replacement therapy included the treatment of anemia, renal osteodistrophy, 
and hypertension, and vitamins were administered as the patients on continues dialysis. He 
was at good status after 3 month dialysis freedom protocol. His BMI was also not differ 
during the study and was 18. He started hemodialysis via Atrio-Venous fistula due to non 
compliance to continue dialysis free protocol (Table 1). 
 
Case 4:  A 24 year old girl with ESRD with unknown cause admitted to our university 
hospital due to complications of dialysis. Jugular vein catheter was inserted and hemodialysis 
started  and  continued  for  5  sessions.  Due  to  catheter  malfunction,  hemodialysis  was 
discontinued  and  her  dialysis  catheter  was  removed.  Due  to  patient  incompliance  with 
hemodialysis catheter re-insertion, dialysis free protocol was begun. Routine laboratory tests 
including  renal  function  tests  were  performed  monthly  and  the  patient  was  clinically 
evaluated for uremic symptoms, nutritional status and need for dialysis. She was also on other 
medications including replacement therapy for anemia (erythropoietin, folate, vitamins) renal 
osteodistrophy (calcitriol, calcium carbonate) and hypertension. This protocol was continued 
for 6 months, and the patient was well and without need to dialyze. Her BMI was also 26 and 
he had 4 kg weight gains during the study. Now she is candidate for renal transplantation 
from living unrelated donor (Table 1). 
 
Case  5:  A  54  year  old  woman  with  ESRD  due  to  unknown  cause  was  referred  to  our 
university clinic for to begin dialysis. She had no dialysis access and disagreed with transient 
intravenous catheter insertion. She had nausea and her estimated GFR was about 6%. Due to 
incompliance with dialysis initiation, and acceptance of our protocol, dialysis free protocol 
was started. Renal function tests, Hb, and nutritional status were evaluated periodically. She 
was  also  on  other  medications  for  treatment  of  anemia,  hypertension,  edema,  and  renal 
osteodistrophy. After 6 months she was in a good clinical and laboratory condition without 
uremia symptoms and need for emergency dialysis. Her BMI was more than 25 without 
weight loss during the study period (Table 1).  
 
DISCUSSION: In many geographic areas most patients with ESRD are treated with chronic 
dialysis  or  kidney  transplantation.  However,  in  many  others  areas  social,  ethical,  and 
financial considerations, in addition to inadequate facilities, government funding, and public 
acceptance  affects  renal  replacement  therapy.  Nevertheless,  the  lack  of  effective  RRT  in 
many areas of the world should not mean that patients with ESRD must be left without 
suitable  care  alternatives  (13).  There  are  many  methods  being  developed  by  many 
investigators from differing cultures and geographic areas for patients who can not continue 
routine RRT (especially dialysis) for many reasons. We used a regimen of low protein diet, Functional Foods in Health and Disease 2012, 2(8):300-306                                                      Page 304 of 306  
with high biologic value in our protocol. The use of low protein diet,  high biologic value 
proteins, and special formula, is one of the methods that could potentially alleviate the need 
for RRT in predialysis state (4-6). Low protein diet with the addition of Acacia gum (1 
g/kg/day) is another regimen that has recently been reported to be a successful alternative to 
dialysis  for  some  ESRD  patients  (13,14).  One  other  part  of  our  protocol  is  the  use  of 
adsorbents  with  a  reasonable  affinity  to  intestinal  nitrogenous  waste  product.  Activated 
charcoal in doses of 30 to 45 gram daily (15 g in a glass of water with each meal) was 
administered. Intestinal dialysis and use of adsorbent such as activated charcoal or AST 120 
with  some affinity to  intestinal nitrogenous  waste products,  is  another  known method  of 
decreasing the need for dialysis in ESRD patients (15). Studies of intestinal dialysis have 
shown a daily flow of 71 grams of urea, 2.9 grams of creatinine, 2.5 grams of uric acid and 
2.0  grams  of  phosphate  into  the  intestinal  fluid  (16).  Accordingly,  various  invasive  and 
noninvasive attempts including external gut fistula, intestinal dialysis, induced diarrhea, and 
administration of oral sorbents and/or encapsulated urease enzyme have been made to extract 
uremic waste from the gastrointestinal tract (2,3,7-15).  
The  second  part  of  our  protocol  was  the  use  of  prebiotic.  We  used  lactulose  as  a 
prebiotic  in  this  study.  In  one  study,  supplemental  nutrition  with  probiotic  activity  that 
improved gastrointestinal flora, and diets rich in prebiotics (such as lactulose, inulin, and 
oligofroctose)  have  been  used  for  delaying  the  need  for  dialysis  in  some  areas.  Various 
therapies have been developed to regulate the complex bacterial fermentation processes (17) 
Younes and coworkers demonstrated that fermentable carbohydrates alter colonic bacterial 
fermentation  in  CKD  (18-19).  In  other  studies,  they  demonstrated  that  the  prebiotic 
oligofructose-enriched  inulin  reduced  urinary  p-cresol  excretion  (including  its  sulfate 
conjugate) in healthy volunteers. Whether fermentable carbohydrates, such as oligofructose 
and inulin, affect serum concentrations of protein-bound uraemic retention solutes in patients 
with CKD is not known (20). To our knowledge, this is the first report regarding the use of 
this combination of regimens (low protein diet, adsorbents, and prebiotics) in order to reduce 
the need for dialysis in ESRD patients. Our criteria for selecting the patients for protocol 
were adult ESRD patients without indication of emergent need for dialysis, and agreed to and 
tolerated the use of this regimen. This protocol is safe and useful for at least: patients with 
ESRD who have access failure and who are candidates for renal transplantation during the 
next few months, patients who need  transient intravenous catheter insertion for a few months 
to  facilitate  Atrio-Venous  fistula  maturation,  andpatients  who  disagree  with  or    socio-
economically unable to begin dialysis. Our protocol also saves more money. The cost of one 
monthof dialysis in our country is at least $1,000, and central venous catheter insertion is an 
invasive and expensive procedure with several complications. Dialysis is also an invasive 
procedure with some morbidity and mortality. Our protocol cost is less than 10% of dialysis 
cost, and is noninvasive. 
 
CONCLUSION: It seems that dialysis freedom protocol is safe and even necessary for some 
ESRD patients who have access problems, are economically disadvantaged, or who disagree 
with beginning dialysis and/or are candidates for renal transplantation within the next few 
months. 
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